Appendix D
Registered Attendees
Brian Abbott
AstraZeneca Pharmaceuticals
Nathan Adams
Defense Threat Reduction Agency, Department of Defense
Margaret Anderson
FasterCures
Euan Ashley
Stanford University
Christopher Austin
National Center for Advancing Translational Sciences, National Institutes of Health
Sarah Beachy
National Cancer Institute, National Institutes of Health
Judith Benkendorf
American College of Medical Genetics
Anahita Bhathena
Abbott Laboratories
Paul Billings
Life Technologies
Bruce Blumberg
Kaiser Permanante
Denise Bonds
National Heart, Lung, and Blood Institute, National Institutes of Health
Ann Bonham
Association of American Medical Colleges
Kristopher Bough
National Institute on Drug Abuse, National Institutes of Health
Joann Boughman
American Society of Human Genetics
Khaled Bouri
U.S. Food and Drug Administration
Linda Brady
National Institutes of Health
Apryl Brown
Wayne County Community College District
Wylie Burke
University of Washington
Walter Capone
Multiple Myeloma Research Foundation
Carolyn Carroll
STAT TECH Inc.
Christine Carter
Society for Women’s Health Research
C. Thomas Caskey
Baylor College of Medicine
Chia-Chien Chiang
Human Genome Sciences, Inc.
Lisa Chong
Science
Melina Cimler
Illumina
Sara Copeland
Health Resources and Services Administration
Sean David
Stanford University School of Medicine
Nicholas Davies
PricewaterhouseCoopers LLP
Silvana Dean
U.S. Food and Drug Administration
Jamie Driscoll
National Institute of Mental Health, National Institutes of Health
Rade Drmanac
Complete Genomics
Deborah Dunsire
Millennium: The Takeda Oncology Company
Victor Dzau
Duke University Health System
Peggy Eastman
Oncology Times
Amy Efantis
Boehringer Ingelheim Pharmaceuticals, Inc.
Raith Erickson
Complete Genomics
Cynthia Ewel
Medco Research Institute
W. Gregory Feero
National Human Genome Research Institute, National Institutes of Health
Mandy Field
Children’s National Medical Center
Gary Filerman
Atlas Health Foundation
Ross Filice
U.S. Food and Drug Administration
Kelly Filipski
National Cancer Institute
Andrew Fish
AdvaMedDx
Garret FitzGerald
Perelman School of Medicine, University of Pennsylvania
Cathy Fomous
National Institutes of Health
Richard Forshee
U.S. Food and Drug Administration
Jane Fridlyand
Genentech
Felix Frueh
Medco Research Institute
Dean Gaalaas
EdgeBio
Ron Galloway
Method Content LLC
John Gardenier
Independent
Turkan Gardenier
Pragmatica Corporation
Fathia Gibril
U.S. Food and Drug Administration
Geoffrey Ginsburg
Duke University
Andrea Giuffrida
National Institutes of Health
Evan Hadley
National Institute on Aging, National Institutes of Health
Margaret Hamburg
U.S. Food and Drug Administration
Steffan Ho
Pfizer Inc.
Carolyn Hoban
Multiple Myeloma Research Foundation
Damon Hostin
Complete Genomics
Florence Houn
Celgene
Kathy Hudson
National Center for Advancing Translational Sciences, National Institutes of Health
Sheikh Mohammed Shariful Islam
International Centre for Diarrhoeal Disease Research, Bangladesh
Jean Jenkins
National Human Genome Research Institute, National Institutes of Health
Justin Johnson
EdgeBio
Carolyn Jones
Biogen Idec
Thea Kalebic
Millennium: The Takeda Oncology Company
Francis Kalush
Center for Devices and Radiological Health, U.S. Food and Drug Administration
Sharon Kardia
University of Michigan
Nobuko Katagiri
U.S. Food and Drug Administration
John Kehne
Translational Neuropharmacology Consulting LLC
John Kenten
Mesoscale Diagnostics
Mohamed Khan
British Columbia Cancer Agency
Muin Khoury
Centers for Disease Control and Prevention
Chava Kimchi-Sarfaty
U.S. Food and Drug Administration
Roger Klein
Esther & Hyman Rapport Philanthropic Trust
Hon-Sum Ko
U.S. Food and Drug Administration
Susan Koester
National Institute of Mental Health, National Institutes of Health
Kathy Kopnisky
National Institutes of Health
Courtney Lang
Pepperdine University
Thomas Lehner
National Institute of Mental Health, National Institutes of Health
Debra Leonard
Weill Cornell Medical Center
Emily Levy
Synergy Partners
Michelle Lewis
Johns Hopkins University
Len Lichtenfeld
American Cancer Society
Michele Lloyd-Puryear
Office of Rare Diseases Research, National Institutes of Health
Laurence McCarthy
Scientific Technologies & Solutions, LLC
Michael McCaughan
RPM Report
Robert McCormack
Veridex, LLC
Kathryn McLaughlin
Health Resources and Services Administration
Melodi McNeil
Abbott Laboratories
Amy Miller
Personalized Medicine Coalition
Helen Moore
National Cancer Institute, National Institutes of Health
Richard Morris
National Institutes of Health
Peter Mueller
Vertex Pharmaceuticals
Arnulfo Muralles
American Association for the Advancement of Science
Laura Nisenbaum
Eli Lilly and Company
Lolita O’Donnell
Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury
Steve Olson
Independent Consultant
Michael Pacanowski
U.S. Food and Drug Administration
Gustavo Palacios
Center for Genomic Sciences
Gary Palmer
Foundation Medicine
Lydia Pan
Pfizer Inc.
Gillian Parrish
FasterCures
Praveen Pendyala
Center for Studying Health System Change
Michelle Penny
Eli Lilly and Company
Margaret Piper
BlueCross BlueShield Association
Laura Povlich
U.S. House of Representatives
Aidan Power
Pfizer Inc.
Arundeep Pradhan
Oregon Health & Science University
Victoria Pratt
Quest Diagnostics
Ronald Przygodzki
Department of Veterans Affairs
Drena Reaves-Bey
Parenting Before Conception
Cynthia Reilly
American Society of Health-System Pharmacists
Jon Retzlaff
American Association for Cancer Research
Max Robinowitz
U.S. Food and Drug Administration
Bob Roehr
British Medical Journal
Allen Roses
Duke University
Deborah Runkle
American Association for the Advancement of Science
Lisa Schlager
Facing Our Risk of Cancer Empowerment
Derek Scholes
National Human Genome Research Institute, National Institutes of Health
Amber Scholz
President’s Council of Advisors on Science and Technology
Joan Scott
National Coalition for Health Professional Education in Genetics
Sam Shekar
Northrop Grumman
Vijaya Simhadri
Center for Biologics Evaluation and Research, U.S. Food and Drug Administration
Tania Simoncelli
U.S. Food and Drug Administration
Dee Simons
Biogen Idec
James Sorace
U.S. Department of Health and Human Services
Ansalan Stewart
U.S. Department of Health and Human Services
Carol Stinson
AstraZeneca Pharmaceuticals
Katherine Johansen Taber
American Medical Association
Zivana Tezak
U.S. Food and Drug Administration
Barry Thompson
American College of Medical Genetics
Javier Torres-Roca
H. Lee Moffitt Cancer Center
Mark Trusheim
MIT Sloan School of Management
Kenneth Tucker
Tauri Group, Inc.
Simona Volpi
National Human Genome Research Institute, National Institutes of Health
Amelia Warner
Merck
Daniel Wattendorf
Department of the Air Force
Jill Wechsler
Pharmaceutical Executive Magazine
Cole Werble
RPM Report
Catherine Wicklund
Northwestern University
Erin Wilhelm
Georgetown University
Hui-Hsing Wong
U.S. Department of Health and Human Services